Star Combo Pharma Ltd (S66) - Total Liabilities

Latest as of December 2025: AU$8.30 Million AUD ≈ $5.88 Million USD

Based on the latest financial reports, Star Combo Pharma Ltd (S66) has total liabilities worth AU$8.30 Million AUD (≈ $5.88 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Star Combo Pharma Ltd to track the company's year-over-year net asset growth rate.

Star Combo Pharma Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Star Combo Pharma Ltd's total liabilities have evolved over time, based on quarterly financial data. See Star Combo Pharma Ltd (S66) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Star Combo Pharma Ltd Competitors by Total Liabilities

The table below lists competitors of Star Combo Pharma Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Agripower France Sa PA:ALAGP	France	€6.71 Million
Nidaros Sparebank OL:NISB	Norway	Nkr4.41 Billion
RE Royalties Ltd V:RE	Canada	CA$45.99 Million
Suryalakshmi Cotton Mills Limited NSE:SURYALAXMI	India	Rs4.53 Billion
Welcron Hantec Co.Ltd KQ:076080	Korea	₩96.14 Billion
Bionano Genomics Inc NASDAQ:BNGO	USA	$29.16 Million
Medicon Hellas S.A. AT:MEDIC	Greece	€14.85 Million
TR Property Investment Trust plc LSE:TRY	UK	GBX149.71 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Star Combo Pharma Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Star Combo Pharma Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.64	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Star Combo Pharma Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Star Combo Pharma Ltd (2016–2025)

The table below shows the annual total liabilities of Star Combo Pharma Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$10.19 Million ≈ $7.21 Million	+9.50%
2024-06-30	AU$9.30 Million ≈ $6.58 Million	+3.76%
2023-06-30	AU$8.97 Million ≈ $6.35 Million	+11.56%
2022-06-30	AU$8.04 Million ≈ $5.69 Million	+12.75%
2021-06-30	AU$7.13 Million ≈ $5.04 Million	-30.22%
2020-06-30	AU$10.22 Million ≈ $7.23 Million	+36.12%
2019-06-30	AU$7.51 Million ≈ $5.31 Million	+170.36%
2018-06-30	AU$2.78 Million ≈ $1.96 Million	-23.62%
2017-06-30	AU$3.64 Million ≈ $2.57 Million	+13.40%
2016-06-30	AU$3.21 Million ≈ $2.27 Million	--

About Star Combo Pharma Ltd

AU:S66 Australia Household & Personal Products

Market Cap

$12.43 Million

AU$17.56 Million AUD

Market Cap Rank

#26469 Global

#1212 in Australia

Share Price

AU$0.13

Change (1 day)

+0.00%

52-Week Range

AU$0.11 - AU$0.27

All Time High

AU$1.72